vs
自然阳光（NATR）与LiveRamp Holdings, Inc.（RAMP）财务数据对比。点击上方公司名可切换其他公司
LiveRamp Holdings, Inc.的季度营收约是自然阳光的1.7倍（$212.2M vs $123.8M），LiveRamp Holdings, Inc.净利率更高（18.8% vs 3.3%，领先15.5%），LiveRamp Holdings, Inc.同比增速更快（8.6% vs 4.7%），过去两年LiveRamp Holdings, Inc.的营收复合增速更高（11.1% vs 5.6%）
自然阳光产品公司（简称NSP）主营膳食补充剂与个人护理产品的生产制造，产品涵盖草本补充剂、维生素、矿物质制剂等品类。公司总部设于犹他州利希，生产工厂位于犹他州西班牙福克，是该领域知名的健康产品生产商。
LiveRamp Holdings, Inc.是一家美国SaaS企业，核心业务为提供数据连接平台，服务涵盖数据导入、线下数据线上迁移等能力，助力企业开展营销相关的数据应用，为品牌及营销从业者的数字化运营提供技术支撑。
NATR vs RAMP — 直观对比
营收规模更大
RAMP
是对方的1.7倍
$123.8M
营收增速更快
RAMP
高出3.9%
4.7%
净利率更高
RAMP
高出15.5%
3.3%
两年增速更快
RAMP
近两年复合增速
5.6%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $123.8M | $212.2M |
| 净利润 | $4.1M | $39.9M |
| 毛利率 | 72.5% | 71.9% |
| 营业利润率 | 4.3% | 18.6% |
| 净利率 | 3.3% | 18.8% |
| 营收同比 | 4.7% | 8.6% |
| 净利润同比 | 1379.4% | 255.7% |
| 每股收益（稀释后） | $0.23 | $0.62 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NATRRAMP
| Q4 25 | $123.8M | $212.2M | ||
| Q3 25 | $128.3M | $199.8M | ||
| Q2 25 | $114.8M | $194.8M | ||
| Q1 25 | $113.2M | $188.7M | ||
| Q4 24 | $118.2M | $195.4M | ||
| Q3 24 | $114.6M | $185.5M | ||
| Q2 24 | $110.6M | $176.0M | ||
| Q1 24 | $111.0M | $171.9M |
净利润NATRRAMP
| Q4 25 | $4.1M | $39.9M | ||
| Q3 25 | $5.3M | $27.4M | ||
| Q2 25 | $5.3M | $7.7M | ||
| Q1 25 | $4.7M | $-6.3M | ||
| Q4 24 | $-321.0K | $11.2M | ||
| Q3 24 | $4.3M | $1.7M | ||
| Q2 24 | $1.3M | $-7.5M | ||
| Q1 24 | $2.3M | $-5.4M |
毛利率NATRRAMP
| Q4 25 | 72.5% | 71.9% | ||
| Q3 25 | 73.3% | 70.2% | ||
| Q2 25 | 71.7% | 70.1% | ||
| Q1 25 | 72.1% | 69.3% | ||
| Q4 24 | 72.0% | 71.9% | ||
| Q3 24 | 71.3% | 72.4% | ||
| Q2 24 | 71.4% | 70.6% | ||
| Q1 24 | 71.2% | 72.2% |
营业利润率NATRRAMP
| Q4 25 | 4.3% | 18.6% | ||
| Q3 25 | 7.0% | 10.7% | ||
| Q2 25 | 3.7% | 3.7% | ||
| Q1 25 | 5.4% | -6.1% | ||
| Q4 24 | 3.8% | 7.5% | ||
| Q3 24 | 4.6% | 4.0% | ||
| Q2 24 | 5.1% | -3.0% | ||
| Q1 24 | 4.2% | -8.3% |
净利率NATRRAMP
| Q4 25 | 3.3% | 18.8% | ||
| Q3 25 | 4.2% | 13.7% | ||
| Q2 25 | 4.6% | 4.0% | ||
| Q1 25 | 4.2% | -3.3% | ||
| Q4 24 | -0.3% | 5.7% | ||
| Q3 24 | 3.8% | 0.9% | ||
| Q2 24 | 1.2% | -4.3% | ||
| Q1 24 | 2.1% | -3.1% |
每股收益（稀释后）NATRRAMP
| Q4 25 | $0.23 | $0.62 | ||
| Q3 25 | $0.30 | $0.42 | ||
| Q2 25 | $0.28 | $0.12 | ||
| Q1 25 | $0.25 | $-0.10 | ||
| Q4 24 | $-0.02 | $0.17 | ||
| Q3 24 | $0.23 | $0.03 | ||
| Q2 24 | $0.07 | $-0.11 | ||
| Q1 24 | $0.12 | $-0.09 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $93.9M | $403.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $161.6M | $962.3M |
| 总资产 | $261.1M | $1.3B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资NATRRAMP
| Q4 25 | $93.9M | $403.4M | ||
| Q3 25 | $95.6M | $376.9M | ||
| Q2 25 | $81.3M | $371.1M | ||
| Q1 25 | $86.5M | $420.8M | ||
| Q4 24 | $84.7M | $384.3M | ||
| Q3 24 | $78.7M | $348.4M | ||
| Q2 24 | $68.7M | $342.7M | ||
| Q1 24 | $77.8M | $368.9M |
总债务NATRRAMP
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $2.1M | — |
股东权益NATRRAMP
| Q4 25 | $161.6M | $962.3M | ||
| Q3 25 | $166.7M | $943.8M | ||
| Q2 25 | $163.7M | $947.8M | ||
| Q1 25 | $167.1M | $948.9M | ||
| Q4 24 | $161.0M | $957.7M | ||
| Q3 24 | $162.6M | $932.1M | ||
| Q2 24 | $156.4M | $951.9M | ||
| Q1 24 | $159.7M | $949.1M |
总资产NATRRAMP
| Q4 25 | $261.1M | $1.3B | ||
| Q3 25 | $264.8M | $1.2B | ||
| Q2 25 | $254.9M | $1.2B | ||
| Q1 25 | $252.7M | $1.3B | ||
| Q4 24 | $240.9M | $1.3B | ||
| Q3 24 | $245.3M | $1.2B | ||
| Q2 24 | $235.8M | $1.2B | ||
| Q1 24 | $247.3M | $1.2B |
负债/权益比NATRRAMP
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.01× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $9.9M | — |
| 自由现金流经营现金流 - 资本支出 | $7.6M | — |
| 自由现金流率自由现金流/营收 | 6.1% | — |
| 资本支出强度资本支出/营收 | 1.9% | 0.1% |
| 现金转化率经营现金流/净利润 | 2.41× | — |
| 过去12个月自由现金流最近4个季度 | $28.8M | — |
8季度趋势，按日历期对齐
经营现金流NATRRAMP
| Q4 25 | $9.9M | — | ||
| Q3 25 | $18.5M | $57.4M | ||
| Q2 25 | $4.3M | $-15.8M | ||
| Q1 25 | $2.6M | — | ||
| Q4 24 | $12.2M | $45.1M | ||
| Q3 24 | $9.6M | $55.6M | ||
| Q2 24 | $1.3M | $-9.3M | ||
| Q1 24 | $2.2M | — |
自由现金流NATRRAMP
| Q4 25 | $7.6M | — | ||
| Q3 25 | $16.8M | $56.8M | ||
| Q2 25 | $3.0M | $-16.2M | ||
| Q1 25 | $1.5M | — | ||
| Q4 24 | $10.0M | $44.8M | ||
| Q3 24 | $7.9M | $55.4M | ||
| Q2 24 | $-2.0M | $-9.6M | ||
| Q1 24 | $-1.5M | — |
自由现金流率NATRRAMP
| Q4 25 | 6.1% | — | ||
| Q3 25 | 13.1% | 28.4% | ||
| Q2 25 | 2.6% | -8.3% | ||
| Q1 25 | 1.3% | — | ||
| Q4 24 | 8.5% | 22.9% | ||
| Q3 24 | 6.9% | 29.8% | ||
| Q2 24 | -1.9% | -5.4% | ||
| Q1 24 | -1.4% | — |
资本支出强度NATRRAMP
| Q4 25 | 1.9% | 0.1% | ||
| Q3 25 | 1.3% | 0.3% | ||
| Q2 25 | 1.2% | 0.2% | ||
| Q1 25 | 1.0% | 0.2% | ||
| Q4 24 | 1.9% | 0.1% | ||
| Q3 24 | 1.5% | 0.1% | ||
| Q2 24 | 3.0% | 0.1% | ||
| Q1 24 | 3.3% | 1.0% |
现金转化率NATRRAMP
| Q4 25 | 2.41× | — | ||
| Q3 25 | 3.46× | 2.09× | ||
| Q2 25 | 0.81× | -2.04× | ||
| Q1 25 | 0.55× | — | ||
| Q4 24 | — | 4.02× | ||
| Q3 24 | 2.21× | 32.10× | ||
| Q2 24 | 0.97× | — | ||
| Q1 24 | 0.94× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NATR
| Other | $68.1M | 55% |
| General Health Products | $20.2M | 16% |
| Digestive Products | $13.8M | 11% |
| Cardiovascular Products | $12.1M | 10% |
| Personal Care Products | $4.4M | 4% |
| Immunity Products | $3.1M | 3% |
| Weight Management Products | $2.1M | 2% |
RAMP
暂无分部数据
